NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: British Journal of Cancer, 115, 10, S. 1264-1272
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2016
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2016
- Urheber
-
Prochazka, Katharina T.
Melchardt, Thomas
Posch, Florian
Schlick, Konstantin
Deutsch, Alexander
Beham-Schmid, Christine
Weiss, Lukas
Gary, Thomas
Neureiter, Daniel
Klieser, Eckhard
Greil, Richard
Neumeister, Peter
Egle, Alexander
Pichler, Martin
- DOI
-
10.1038/bjc.2016.325
- URN
-
urn:nbn:de:bvb:384-opus4-1028432
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Prochazka, Katharina T.
- Melchardt, Thomas
- Posch, Florian
- Schlick, Konstantin
- Deutsch, Alexander
- Beham-Schmid, Christine
- Weiss, Lukas
- Gary, Thomas
- Neureiter, Daniel
- Klieser, Eckhard
- Greil, Richard
- Neumeister, Peter
- Egle, Alexander
- Pichler, Martin
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2016
Ähnliche Objekte (12)
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients
Best of ASCO 2022: bladder cancer
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large b-cell lymphoma patients
Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement
Panel sequencing of primary cutaneous B-cell lymphoma
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients
Best of ASCO 2022: bladder cancer
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large b-cell lymphoma patients
Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement
Panel sequencing of primary cutaneous B-cell lymphoma
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients
Best of ASCO 2022: bladder cancer
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large b-cell lymphoma patients
Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement